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Introduction
Balancing cell death and cell survival enables structural plas-
ticity and homeostasis, regeneration, and repair and fails in can-
cer and neurodegeneration. In the nervous system, cell number 
plasticity is linked to neural circuit formation, adjusting neuro-
nal number to functional requirements (Levi-Montalcini, 1987). 
In mammals, the neurotrophin (NT) protein family—NGF, 
brain-derived neurotrophic factor (BDNF), NT3, and NT4—
regulates neuronal number through two mechanisms. First, 
full-length pro-NTs, comprised of a disordered prodomain and 
a cystine-knot (CK) domain, induce cell death; in contrast, ma-
ture NTs formed of CK dimers promote cell survival (Lu et al., 
2005). Second, pro-NTs bind p75NTR and Sortilin receptors, 
inducing apoptosis via JNK signaling, whereas mature NTs 
bind p75NTR, promoting cell survival via NF-κB (Carter et al., 
1996) and TrkA, B, and C, promoting cell survival via PI3K/
AKT and MAPK/ERK (extracellular signal-related kinase; Lu 
et al., 2005). As the NTs also regulate connectivity and syn-
aptic transmission, they couple the regulation of cell number 
to neural circuitry and function, enabling structural brain plas-
ticity (Lu et al., 2005; Minichiello, 2009; Park and Poo, 2013). 
There is abundant evidence that cell number plasticity occurs in 
Drosophila melanogaster central nervous system (CNS) devel-
opment, with neurotrophic factors including NTs and mesen-
cephalic astrocyte-derived neurotrophic factor (MANF; Zhu et 
al., 2008; Palgi et al., 2009), but fruit flies lack p75NTR and Trk 
receptors, raising the question of how this is achieved in the fly. 
Finding this out is important, as it could lead to novel mecha-
nisms of structural plasticity for both flies and humans.
The Drosophila NTs (DNTs) Spätzle (Spz), DNT1, and 
DNT2 share with mammalian NTs the characteristic structure 
of a prodomain and a conserved CK of 13–15 kD, which forms 
a disulfide-linked dimer (Hoffmann et al., 2008a,b; Zhu et al., 
2008; Arnot et al., 2010; Hepburn et al., 2014). Spz resem-
bles NGF biochemically and structurally, and the binding of 
its Toll-1 receptor resembles that of NGF to p75NTR (DeLotto 
and DeLotto, 1998; Mizuguchi et al., 1998; Arnot et al., 2010; 
Lewis et al., 2013; Hepburn et al., 2014). DNT1 (also known as 
spz2) was discovered by homology to BDNF, and DNT2 (also 
known as spz5) as a paralogue of spz and DNT1 (Parker et al., 
2001; Zhu et al., 2008). DNT1 and 2 promote neuronal survival, 
and DNT1 and 2, Spz, and Spz3 are required for connectivity 
and synaptogenesis (Zhu et al., 2008; Sutcliffe et al., 2013; Ballard 
et al., 2014). Spz, DNT1, and DNT2 are ligands for Toll-1, -7, and 
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-6, respectively, which function as NT receptors and promote 
neuronal survival, circuit connectivity, and structural synaptic 
plasticity (Weber et al., 2003; Zhu et al., 2008; McIlroy et al., 
2013; Sutcliffe et al., 2013; Ward et al., 2015; McLaughlin et 
al., 2016). Tolls belong to the Toll receptor superfamily, which 
underlies innate immunity (Imler and Zheng, 2004; Leulier 
and Lemaitre, 2008). There are nine Toll paralogues in flies, 
of which only Toll-1, -5, -7, and -9 are involved in immunity 
(Tauszig et al., 2000; Leulier and Lemaitre, 2008). Tolls are also 
involved in morphogenesis, cell competition, and epidermal re-
pair (Halfon et al., 1995; Yagi et al., 2010; McIlroy et al., 2013; 
Ballard et al., 2014; Carvalho et al., 2014; Meyer et al., 2014; 
Paré et al., 2014; Ward et al., 2015). Whether DNTs and Tolls 
can balance cell number plasticity is unknown.
Like the p75NTR receptor, Toll-1 activates NF-κB (a po-
tent neuronal prosurvival factor with evolutionarily conserved 
functions also in structural and synaptic plasticity) signaling 
downstream (Hoffmann and Reichhart, 2002; Mattson and 
Meffert, 2006; Gutierrez and Davies, 2011). Toll-1 signaling 
involves the downstream adaptor MyD88, which forms a com-
plex with Tube and Pelle (Horng and Medzhitov, 2001; Tauszig- 
Delamasure et al., 2002; Gay and Gangloff, 2007). Activation 
of Toll-1 triggers the degradation of the NF-κB inhibitor Cac-
tus, enabling the nuclear translocation of the NF-κB homo-
logues Dorsal and Dorsal-related immunity factor (Dif), which 
function as transcription factors. Other Tolls have also been 
suggested to activate NF-κB (McIlroy et al., 2013; Meyer et al., 
2014). However, only Toll-1 has been shown to bind MyD88 
(Tauszig-Delamasure et al., 2002), raising the question of how 
the other Tolls signal in flies.
Whether Tolls regulate cell death is also obscure. Toll-1 
activates JNK, causing apoptosis, but its expression can also be 
activated by JNK to induce nonapoptotic cell death (Liu et al., 
2015; Wu et al., 2015a,b). Toll-2, -3, -8, and -9 can induce apop-
tosis via NF-κB and dSarm independently of MyD88 and JNK 
(Meyer et al., 2014). However, in the CNS, dSarm induces ax-
onal degeneration, but there is no evidence that it can promote 
apoptosis in flies (Osterloh et al., 2012). In other animals, Sarm 
orthologues are inhibitors of Toll signaling and MyD88 (Carty 
et al., 2006; Yuan et al., 2010), but there is no evidence that 
dSarm is an inhibitor of MyD88 in Drosophila. Thus, whether 
or how Tolls may regulate apoptosis in flies is unclear.
In the mammalian brain, Toll-like receptors (TLRs) are 
expressed in neurons, where they regulate neurogenesis, apop-
tosis, and neurite growth and collapse in the absence of any 
insult (Okun et al., 2011). However, their neuronal functions 
have been little explored, and their endogenous ligands in 
neurons remain unknown.
Because Toll-1 and p75NTR share common downstream 
signaling pathways and p75NTR can activate NF-κB to promote 
cell survival and JNK to promote cell death, we asked in this 
study whether the DNTs and their Toll receptors could have dual 
roles controlling cell survival and death in the Drosophila CNS.
Results
Different processing for each DNT ligand
Using 3D structural modeling based on the crystal structure of 
Spz (Lewis et al., 2013), we compared the mature CK domains 
of DNTs with those of mammalian NTs. They all share the struc-
turally conserved CK unique to the NT family and distinct from 
those of other growth factors, with the characteristic arrange-
ment of antiparallel β sheets and disulfide bridges (Fig. 1, A–D). 
The overhanging wings are out of phase by 90° in Drosophila 
versus mammalian ligands, possibly reflecting interactions with 
different receptor types (Fig.  1, B–D). The receptor-binding 
interface of Spz is not evolutionarily conserved in DNT1 or 
2, suggesting distinct receptor affinities (Fig. 1 E). Thus, Spz, 
DNT1, and DNT2 are NT ligands with distinctive features.
The prodomains have distinctive features too. The pro-
domains of Spz and DNT2 are disordered coils, whereas that 
of DNT1 has helices, suggesting a globular structure (Figs. 2 
A and S1). The DNT1 prodomain is also twice as long as that 
of DNT2. The prodomain of Spz has an α-helix just upstream 
of the Easter cleavage site, which undergoes a conformational 
change upon cleavage, essential for the activation of Toll (Arnot 
et al., 2010). This sequence is not conserved in the prodomains 
of the mammalian NTs nor in DNT1 and 2 (Fig. 2 A). This sug-
gests that the activation mechanism of Toll by Spz is unique and 
distinct from those of Toll-6 and -7 by DNT2 and 1, respectively.
Mammalian pro-NTs are cleaved intracellularly by furin 
proteases or extracellularly by serine proteases (e.g., BDNF; 
Fig. 2 B). Spz is only secreted full length and is cleaved extra-
cellularly by the serine proteases Easter or Spz processing en-
zyme (Hoffmann and Reichhart, 2002). Furin sites were absent 
from the Spz prodomain, but several highly conserved sites were 
found in DNT1 and 2 (Fig. 2 B). In vivo overexpression of ma-
ture Spz-CK, DNT1-CK, and DNT2-CK is functional and rescues 
the respective mutant phenotypes (Ligoxygakis et al., 2002; Hu 
et al., 2004; Zhu et al., 2008; Sutcliffe et al., 2013). However, 
S2 cells transfected with DNT1–CK–C-terminal domain (CTD) 
tagged with 3×HA (DNT1-CK-CTD-HA) and DNT2-CK-HA 
did not secrete mature DNTs to the S2 cell medium (Fig. 2 D, 
lanes 3 and 8). This either suggests that the prodomain is re-
quired for trafficking in S2 cells or that S2 cells do not behave 
like neurons do in vivo. S2 cells transfected with wild-type full-
length (FL) DNT1-FL-HA did not secrete DNT1-FL either but 
instead secreted a product truncated at the R283 site (Fig. 2 D, 
lane 2), suggesting that cleavage occurs naturally at this site. In 
contrast, S2 cells expressing DNT2-FL-HA invariably secreted 
the mature CK form of 15 kD (Fig. 2 D, lane 7). To test whether 
the conserved furin sites were responsible for these cleavage 
profiles, we performed site-directed mutagenesis of the furin 
sequences in HA-tagged DNT1 and 2 (Fig. 2 C). DNT1 lacking 
the furin site at R499 still secreted a product cleaved at R283, 
but no secreted protein was detected when both R499 and R283 
were mutagenized (Fig. 2 D, lanes 4 and 5). Thus, the DNT1 
furin site at R283, which is the most conserved, is functional. 
Mutagenesis of the DNT2 furin site R284 resulted in the se-
cretion of two products of 30 kD and 18 kD (Fig.  2  D, lane 
10). The 30-kD product corresponds to cleavage at site R214 or 
R221, implying that cleavage at these sites is unlikely to occur 
naturally or that cleavage at R284 predominates. The 18-kD 
product was not detectable in the media expressing wild-type 
DNT2, suggesting that it does not occur naturally and is the re-
sult of nonfurin cleavage. Mutagenizing R214, R221, and R284 
sites resulted in the secretion of DNT2-FL-HA from S2 cells, 
showing that DNT2 can be secreted full length (Fig. 2 D, lane 
11). These findings showed that the DNT2 furin cleavage site at 
R284 is functional and is the predominant cleavage site.
To test whether similar DNT processing occurs in vivo, 
we overexpressed in the retina (with GMR-GAL4) full-length 
forms tagged at the C termini with GFP and visualized the re-
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sulting products with anti-GFP in Western blots. DNT1 was 
predominantly found in full-length form and also cleaved at 
furin sites at 98 (less abundant), 283 (pro-DNT1), and 499 
(DNT1-CK-CTD; Fig. 2 E). DNT2 was found full length, but 
predominantly in mature form (DNT2-CK; Fig.  2  E). These 
data show that in vivo, DNTs are cleaved by furins and can be 
found in both pro- and mature forms.
To conclude, each DNT has unique features. DNT1 is 
more likely found in pro- form than DNT2, and DNT2 is more 
likely found in mature form. Ultimately, the forms secreted in 
vivo will depend on the expression profile of proteases and will 
be context dependent. The distinct processing mechanisms of 
Spz, DNT1, and DNT2 suggest functional differences.
Pro-DNT1 activates proapoptotic and 
mature DNT prosurvival pathways
To ask whether different DNT forms could have distinct func-
tions, we tested whether they could activate proapoptotic or pro-
survival signaling pathways.
Overexpression of mature DNT1 and 2 promotes cell sur-
vival in embryos (Zhu et al., 2008). In mammals, apoptosis is 
activated by pro-NTs binding p75NTR and activating JNK (Roux 
and Barker, 2002). Thus, we asked whether the different DNT 
forms activate JNK signaling, visualized using antiphospho-JNK 
antibodies. Overexpression of DNT1-CK-CTD, DNT2-CK, or 
DNT2-FL in the retina reduced the number of pJNK+ cells com-
pared with controls, whereas overexpression of DNT1-FL in-
creased pJNK+ cell number (Fig. 3 A). Most likely, DNT2-FL 
was cleaved intracellularly and secreted as mature CK in-
stead (Fig. 2, D and E). Thus, pro-DNT1 can activate the JNK 
proapoptotic signaling pathway.
We next tested whether DNTs can activate the prosurvival 
pathways NF-κB and ERK. Stimulating S2 cells with purified 
mature DNT2-CK induced the phosphorylation of Dorsal (i.e., 
activation; Fig. 3 B). We also transfected S2 cells with Toll-6 or 
-7, stimulated them with purified mature DNT2-CK, and tested 
whether it triggered the nuclear translocation of Dorsal or Dif, 
thus activating NF-κB signaling. Subcellular fractionation re-
vealed that DNT2 induced the degradation of the NF-κB inhibi-
tor Cactus in the cytoplasm and the nuclear translocation of both 
Dorsal and Dif (Figs. 3 C and S2 A). These data demonstrate 
that mature DNT2-CK activates NF-κB signaling. Stimulation 
with DNT2-CK also activated signaling in nontransfected con-
trol cells (Fig. 3 C). Because S2 cells express multiple Tolls, but 
not Toll-6 (Fig. S2 B), this means that DNT2 can also bind other 
Toll family receptors. In fact, DNT1 binds Toll-7 and DNT2 
binds Toll-6 (McIlroy et al., 2013), but DNT1 could also bind 
Toll-6 and DNT2 could also bind Toll-7 (Fig. S3). Thus, bind-
ing of DNT1 and 2 to Toll-6 and -7 is promiscuous. Importantly, 
both Cactus degradation and nuclear translocation of Dorsal 
and Dif induced by DNT2 were more pronounced in transfected 
cells than in mock controls (Fig. 3 C). This shows that Toll-6 
and -7 activate NF-κB signaling downstream of DNT2.
To test whether DNTs, Toll-6, and Toll-7 could acti-
vate ERK, we overexpressed them and visualized activated 
antiphospho-ERK. Overexpression of either DNT1-FL or 
mature spz-CK in neurons of the larval brain optic lobe (with 
Figure 1. Structural models of DNTs compared with Spz and mammalian 
NTs. (A–D) Crystal structures and homology models of mammalian NTs 
and DNTs compared in the same orientation relative to the CK. PDB 
code 1BET corresponds to the crystal structure of NGF as determined 
by McDonald et al. (1991), and 3BUK and 1HCF correspond to the 
crystal structures of NT3 in complex with p75 (Gong et al., 2008) and 
NT4/5 bound to TrkB (Banfield et al., 2001). Representations in A, B, 
and D are cartoons, in B’ and D’ are molecular surfaces color coded 
by protomers, and in B’’ and D’’ are surface charge distributions with 
gradients from red to white to blue, corresponding with electronega-
tive to neutral to positively charged molecular surfaces. Mammalian 
NTs (A and B, BDNF; D, NGF) and DNTs (B and D) have conserved 
CK but deviating β-hairpin wings. Compare Spz and NGF (A and D) 
and DNT2 (green and gray) with BDNF (magenta and gray) in ribbon 
representation (C). (E) Spz residues mediating Toll-1 binding are not 
conserved among DNTs. Clustal annotations marked by asterisks were 
used for identical residues, and colons mark increased similarity be-
tween residues. Spz residues from the proximal Spz chain interfacing 
with Toll-1 are in red, Spz residues from the distal Spz chain are in 
yellow, and blue triangles indicate conserved areas. Of 33 Toll-contact 
residues in Spz, only 11 are conserved in DNT1 and 2, with a single 
identical residue Tyr64 in Spz.
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Figure 2. DNT1 and 2 are cleaved by conserved furin proteases. (A) The prodomain α-helix of Spz (boxes) required to activate Toll-1 is not conserved in 
DNT1 and 2. Yellow highlights indicate corresponding sequences that are not conserved. (B) The prodomains of DNT1 and 2 but not Spz have conserved furin 
sites. c.s., cleavage site. (C) Site-directed mutagenesis of furin sequences. Red letters mark amino acid substitutions. (D) Mutant DNT1-FL-HA and DNT2-FL-HA 
forms expressed in S2 cells and visualized in Western blots with anti-HA from lysate and secreted medium. Black arrows indicate normal forms, and red arrows 
indicate mutant products. (E) Anti-GFP Western blot upon overexpression of C-terminally tagged DNTs in the retina with GMR-GAL4 shows that furin cleavage 
occurs in vivo (black arrows: DNT1, blue arrows: DNT2). Molecular masses on the left of each blot are given in kilodaltons.
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Figure 3. DNTs and Tolls activate proapoptotic and prosurvival pathways. (A) Overexpression of DNTs in larval retina with GMR-GAL4–altered pJNK 
activation. The box plot graph depicts a one-way analysis of variance: ***, P < 0.001; Dunnett’s post-hoc test. (B) Stimulation of S2 cells with purified 
DNT2-CK–induced Dorsal phosphorylation. (C) Stimulation of S2 cells with DNT2-CK provoked the degradation of the cytoplasmic inhibitor Cactus (αCact) 
and the nuclear translocation of Dif (αDif) and Dorsal (αDI), particularly in Toll-6– or -7–transfected cells. Molecular masses are given in kilodaltons. Dotted 
lines indicate that intervening lanes have been spliced out. (D) Overexpression of DNT1-CK-CTD and DNT2-CK, but not DNT1-FL or spz-CK, activated ERK 
(arrows) in RG-GAL4 neurons of the larval optic lobe. n = 5–11. (E) Overexpression of activated Toll-6CY and -7CY in the retina increased pERK (arrows indi-
cate morphogenetic furrow [mf]). GMR-GAL4>TOR DER is a positive control. Error bars display SD (s.d.). One-way analysis of variance: P < 0.0001; Dun-
nett’s post-hoc test. n = 8–13. A, anterior; P, posterior. (F) Distinct effect of loss and gain of function for Tolls in Eve+ neuron numbers in larvae. Dashed lines 
indicate the median (left graph) or 50% of the data distribution in controls (right graph). One-way analysis of variance: ***, P < 0.0001; Dunnett’s post-hoc 
test. n = 5–22. ns, not significant. Asterisks on graphs indicate post-hoc multiple comparisons corrections: **, P < 0.01; ***, P < 0.001. > indicates GAL4/UAS. 
Bars, 50 µm. (G) Different ligand forms and Toll receptors can induce either cell survival or death. For genotypes, statistical details, and sample sizes, see Table S2. 
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RG-GAL4) did not activate ERK signaling (Fig. 3 D). In con-
trast, overexpression of DNT1-CK-CTD and DNT2-CK did 
(Fig. 3 D). DNT2-FL also activated ERK, but as shown in Fig. 2 
(D and E), DNT2 is readily cleaved before secretion. Thus, 
mature DNT1 and 2 (but not Spz) can activate ERK. Further-
more, overexpression of activated forms of Toll-6CY and Toll-7CY 
(McIlroy et al., 2013) in retinae significantly increased pERK 
levels (Fig. 3 E). Thus, Toll-6 and -7 activate ERK. Collectively, 
these data show that DNT1 and 2 can activate the prosurvival 
signaling pathways NF-κB and ERK via Toll-6 and -7 and that 
pro-DNT1 can activate the proapoptotic JNK pathway.
To test whether distinct Toll receptors might differentially 
regulate neuronal number, we asked whether Eve+ neurons were 
affected by loss or gain of function for Tolls in third instar larvae 
ventral nerve cords (VNCs). Toll-7P8/ Toll-7P114; Toll-626/Toll-
631 double mutant larvae had slightly fewer Eve+ neurons than 
wild type, but Toll-1r3/Toll-1r444 mutants had more (Fig. 3 F). 
Conversely, overexpression of constitutively active Toll-6CY and 
Toll-7CY in neurons (with Elav-GAL4) increased Eve+ neuron 
number (Fig.  3  F), whereas constitutively active Toll-110b de-
creased it (Fig. 3 F). Thus, Toll-6 and -7 promote cell survival 
as previously described (McIlroy et al., 2013), but Toll-1 can be 
proapoptotic. Distinct Toll receptors and the potential formation 
of heterodimers between different Toll receptors might switch 
the response to DNTs from cell survival to cell death (Fig. 3 G).
Toll-6 activates prosurvival signaling in the 
CNS via MyD88
The finding that Toll-6 and -7 could initiate signaling suggested 
the involvement of the MyD88 adaptor. However, no interactions 
between Tolls other than Toll-1 and MyD88 had been previously 
detected (Tauszig-Delamasure et al., 2002). To test whether 
Toll-6 or -7 and MyD88 could form a signaling complex, S2 cells 
were cotransfected with native Toll-6 or -7 or activated Toll-6CY 
or -7CY tagged with Flag and MyD88 tagged with V5. In coimmu-
noprecipitations, MyD88 copurified with Toll-6 and -7 as well 
as Toll-6CY and Toll-7CY (Fig. 4 A). Thus, both Toll-6 and -7 can 
bind MyD88. This physical interaction could occur in vivo, as, 
like Toll-6 and -7 (McIlroy et al., 2013), MyD88 protein was 
found throughout the embryonic CNS neuropile, and its endog-
enously tagged downstream targets Dorsal-GFP and Dif-GFP 
were as well (Fig. 4 B).
We next asked whether MyD88 is required for the CNS 
functions of Toll-6 and -7 by testing the effect of mutants on 
Eve, a reporter for Toll-6 neurons. All Eve+ neurons except 
posterior corner cell (pCC) and RP2 express Toll-6 (McIlroy et 
al., 2013). MyD88kra56 is a hypomorphic allele (Charatsi et al., 
2003), ideal to test for phenotypic enhancement or suppression 
in genetic interactions. MyD88kra56 mutants had a virtually nor-
mal embryonic CNS, but MyD88kra56 Toll-626 double mutants 
and MyD88kra56 Toll-7P8 Toll-626 triple mutants had fewer Eve+ 
neurons (Figs. 4 C and S4). This is consistent with MyD88 
functioning downstream of Toll-6 and -7 in the CNS to main-
tain neuronal survival. In fact, overexpression of MyD88 in all 
neurons (with elav-GAL4) increased Eve+ neurons both in third 
instar larvae and pupae (Fig. 4 D). Conversely, overexpression 
of cactus decreased Eve+ neuron numbers in larvae (Fig. 4 D), 
and loss of MyD88 function also decreased Eve+ numbers in 
pupae (Fig. 4 D). Collectively, these data show that MyD88 is 
required for and can promote neuronal survival.
To verify this, we quantified the effects of altering MyD88 
function in apoptosis. MyD88kra56 homozygotes are semilethal, 
with a lethality phase at pupariation, indicating this is a critical 
time for MyD88 function. Using anti–Death Caspase 1 (Dcp1), 
we counted all dying cells throughout the VNC of white pupae 
using adapted DeadEasy Caspase software (Forero et al., 2009). 
In MyD88kra56 homozygotes, apoptosis levels did not differ from 
controls, but they increased in MyD88kra56/DfBSC279 trans- 
heterozygotes (Fig.  4  E). We generated a MyD88-null allele 
using clustered regularly interspaced short palindromic repeats 
(CRI SPR)/Cas9, MyD88cr2.8.  Trans-heterozygous MyD88cr2.8/
Df(2R)BSC279 pupae also had increased apoptosis (Fig. 4 E). 
Thus, MyD88 is required for neuronal survival. Collectively, 
these data show that Toll-6 and -7 signal via the canonical 
MyD88 pathway to promote neuronal survival in the CNS.
However, overexpression of MyD88 in all neurons also 
increased apoptosis in pupae (Fig.  4  E). This could occur 
downstream of Tolls, as overexpression of activated Toll-6CY 
or Toll-110b also increased apoptosis in pupae (Fig.  4 E). Re-
markably, the proapoptotic effect of Toll-6 was enhanced when 
overexpressed in a MyD88kra56 mutant background (Fig. 4 E), 
suggesting that Toll-6 might induce apoptosis in pupae 
independently of MyD88.
These data raised two questions: How does MyD88 
induce apoptosis? And how can Toll-6 induce apoptosis 
independently of MyD88?
Toll-6 can induce apoptosis via the MyD88 
inhibitor dSarm
In mammals, Sarm1 inhibits MyD88 and can induce neuronal 
apoptosis (O’Neill and Bowie, 2007; Carlsson et al., 2016). 
Thus, we wondered whether Drosophila dsarm might be in-
volved in proapoptotic signaling by Toll-6. We overexpressed 
dsarm in all neurons using EP3610 flies, which drive expres-
sion of multiple Ect4 isoforms (Ect4 is a synonym of dsarm). 
Elav>EP3610 increased apoptosis in pupal VNCs (Fig. 5 A). 
Remarkably, overexpression of dsarm in a MyD88kra56 mu-
tant background increased apoptosis further (Fig. 5 A). This 
showed that dSarm promotes apoptosis and antagonizes 
MyD88 function. Apoptosis led to neuronal loss, as over-
expression of dsarm in normal or MyD88 mutant pupae de-
creased Eve+ neuron number (Fig. 5 B). Because sarm mutants 
are embryonically lethal, to further verify this, we looked at the 
embryonic CNS. dsarm is expressed throughout the embryonic 
CNS, as visualized with a dsarmMIM IC-GFP reporter (Fig. 5 C). 
Overexpressing dsarm using either EP3610 or a single dsarm 
isoform (Osterloh et al., 2012) in all embryonic CNS neu-
rons caused Eve+ neuron loss (Figs. 5 D and S4). Conversely, 
dsarm4705/dsarm4621 mutant embryos had more Eve+ neurons 
(Figs. 5 D and S4). Collectively, these data show that dSarm 
induces apoptosis and neuronal loss.
JNK is a common proapoptotic effector activated by 
p75NTR and Sarm1 in mammals and Tolls in flies (Roux and 
Barker, 2002; Kim et al., 2007; Wu et al., 2015a). Thus, to 
ask whether dSarm induces apoptosis by activating JNK, we 
tested whether JNK knockdown could rescue apoptosis caused 
by dsarm overexpression. Indeed, overexpressing dsarm in all 
neurons together with JNK-RNAi decreased apoptosis com-
pared with Elav>EP3610 (Fig.  5  A). Thus, dSarm activates 
apoptosis via JNK. To further verify this, we asked whether 
MyD88 and dSarm affected activated pJNK+ cells in larval reti-
nae. MyD88kra56/Df(2R)BSC279 mutants had normal pJNK+ cell 
numbers, but overexpressing dsarm increased pJNK+ cell num-
bers (Fig. 5 E), and this increased further in a MyD88kra56 mu-
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Figure 4. Toll-6 promotes cell survival via MyD88. (A) Coimmunoprecipitations showing that MyD88-V5 bound Toll-6–Flag and Toll-7–Flag and activated 
Toll-6CY–Flag and Toll-7CY–Flag. IB, immunoblot; IP, immunoprecipitation. Molecular masses are given in kilodaltons. (B) Anti-MyD88 and exon trap reporters 
Dorsal-GFP and Dif-GFP visualized with anti-GFP are distributed throughout the embryonic CNS neuropile. Left, horizontal views; right, transverse sections; 
white arrows indicate reporter distribution within the neuropile. (C) Loss of Eve+ neurons (arrows) in the CNS in MyD88kra56 Toll-7P8 Toll-626 triple mutant 
embryos. For quantification, see Fig. S4. aCC, anterior corner cell; EL, Eve lateral. (D) Altering MyD88 signaling affects Eve+ neuron number. Dashed 
lines indicate 50% (left graph) or 100% (right graph) data distirbution in controls. Box plots: larvae, one-way analysis of variance, P < 0.001, Dunnett’s 
post-hoc test; pupae, Welch’s analysis of variance, P < 0.01, Dunnett’s post-hoc test. n = 8–12. (E) Apoptotic cells visualized with anti-Dcp1 in white pupal 
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tant background (Fig. 5 E). This showed that dSarm activates 
apoptosis via JNK and antagonizes MyD88 function.
To test whether dSarm could inhibit MyD88 through 
direct physical interaction, we performed coimmunoprecipi-
tations. S2 cells were cotransfected with MyD88 tagged with 
V5 and dsarm tagged with HA. Precipitating MyD88 copuri-
fied dSarm, showing that dSarm and MyD88 interact physically 
(Fig. 5 F). Altogether, our data show that Sarm is an inhibitor of 
MyD88 and it induces apoptosis by antagonizing MyD88 and 
by activating JNK signaling.
But if neuronal apoptosis depends on dSarm, why did 
MyD88 induce apoptosis in pupae? We had shown that overex-
pression of MyD88 increased neuron number, overexpression of 
cactus decreased Eve+ neuron number, and MyD88 loss of func-
tion did not affect pJNK cell number, implying that NF-κΒ does 
not directly promote apoptosis. Importantly, apoptosis caused 
by MyD88 overexpression in neurons was rescued by JNK-
RNAi knockdown (Fig.  5  A), meaning that apoptosis down-
stream of MyD88 requires JNK. This suggests that MyD88 
might induce apoptosis by up-regulating the expression of JNK, 
weckle (wek), or dsarm.
Our data had shown that Toll-6 can induce apoptosis 
and that it functions upstream of MyD88 to maintain neuro-
nal survival, but MyD88 is inhibited by Sarm, which also in-
duces apoptosis via JNK. So we asked whether Toll-6 and -7 
could activate apoptosis by directly interacting with dSarm by 
using coimmunoprecipitations. We cotransfected S2 cells with 
Toll-6–Flag or -7–Flag and dsarm-HA and found that precipi-
tating Toll-6 or -7 did not coprecipitate dSarm (Fig. 5 F). Thus, 
dSarm does not bind Toll-6 or -7, meaning that dSarm does not 
directly mediate the proapoptotic function of Toll-6.
Thus, our data show that Toll-6 functions upstream of 
dSarm and MyD88 to regulate neuronal death and survival, 
respectively (Fig.  5  G). But these data raise further ques-
tions: How can Toll-6 induce apoptosis if it does not bind 
dSarm? And why does Toll-6 promote cell survival in embryos 
and apoptosis in pupae?
Proapoptotic Toll-6 signaling requires Wek
Our data suggest there might be another adaptor linking Toll-6 
to dSarm to enable proapoptotic signaling. Wek is an adaptor 
downstream of Toll-1 that recruits MyD88 to form a signaling 
complex during embryonic development but not in innate im-
munity (Chen et al., 2006). To test whether proapoptotic Toll-6 
signaling requires Wek, we measured apoptosis in the pupal 
VNC with anti-Dcp1 in loss- and gain-of-function genotypes. 
Apoptosis levels decreased in wekEX14/Df(2L)BSC690 mutants 
compared with controls (Fig. 6 A). Conversely, overexpression 
of wek in neurons increased apoptosis (Fig. 6 A). These phe-
notypes were rescued by the overexpression of wek in neurons 
in a wek mutant background (Fig.  6  A). Thus, Wek can pro-
mote apoptosis in the CNS.
To test the relationship of Wek with Toll-6 and dSarm, 
we performed epistasis analyses. Loss of wek function res-
cued the increased apoptosis caused by the overexpression of 
Toll6CY (Fig. 6 A), showing that Toll-6 requires Wek to induce 
apoptosis. Loss of wek function did not rescue the apoptosis 
caused by the overexpression of dsarm, meaning that dSarm 
functions downstream of Wek (Fig. 6 A). Furthermore, dsarm 
knockdown rescued the apoptosis caused by the overexpression 
of wek, showing that Wek induces apoptosis upstream of dsarm 
(Fig.  6  A). In embryos, overexpression of wek caused Eve+ 
neuron loss (Figs. 6 B and S4). In pupae, the number of Eve+ 
neurons did not change in wekEX14/Df(2L)BSC690 mutants, but 
decreased upon wek overexpression (Fig.  6  C). Collectively, 
these data show that Wek can promote apoptosis and neuronal 
loss downstream of Toll-6 and upstream of dSarm.
To test whether Wek could bind Toll-6 and dSarm, we per-
formed coimmunoprecipitations. We cotransfected S2 cells with 
wek-HA and Toll-6–Flag or dsarm–Flag and found that precipi-
tating Toll-6 or dSarm also brought down Wek (Fig. 6 D). Thus, 
Wek can bind both Toll-6 and dSarm.
To conclude, Wek is required downstream of Toll-6 to in-
duce neuronal apoptosis via dSarm (Fig. 6 E). But a question 
still remained: Why could Toll-6 promote cell survival in em-
bryos and cell death in pupae?
Adaptor profiles change in space and time
Our data suggest that the relative levels of MyD88, dSarm, 
and Wek could determine neuronal life or death. Thus, we 
used MyD88-GAL4 to ask how increasing the levels of Wek 
and Sarm relative to normal MyD88 levels would affect neu-
rons. Overexpression of wek in MyD88+ cells decreased Eve+ 
neuron numbers in pupae compared with controls, and over-
expression of sarm (EP3610) decreased Eve+ neurons further 
(Fig. 7 A). Using the nuclear reporter Histone-YFP, overexpres-
sion of wek reduced cell numbers in pupae, and overexpression 
of dsarm reduced cell numbers even further (Fig. 7 B). Remark-
ably, concomitant neuronal overexpression of wek with MyD88 
knockdown resulted in the most severe cell loss in pupal VNCs 
(Fig. 7 B). Because overexpression of wek alone had only a mild 
effect, this reveals that normally Wek is in a tug of war between 
dSarm and MyD88 signaling, that MyD88 and dSarm have 
antagonistic functions regulating cell numbers, and that Wek 
can engage both pathways downstream of Toll-6.  Thus, rela-
tive levels of Wek, Sarm, and MyD88 determine cell survival or 
death downstream of Tolls.
Toll-6 maintains neuronal survival in embryos and can 
promote both neuronal survival and death in pupae, suggesting 
that its signaling adaptors change over time. To test this, we 
used real-time quantitative RT-PCR (qRT-PCR) and measured 
MyD88, dsarm, and wek transcript levels in whole stage 17 em-
bryos and in the dissected CNS of second and third instar lar-
vae (L2 and L3) and 1-d-old pupae. MyD88 mRNA levels were 
high in embryos, decreased in L2 CNS, and increased again 
between L3 and white pupae (Fig.  7  C). Relative to MyD88 
transcripts, dsarm mRNA levels were high in embryos, decreas-
ing thereafter (Fig. 7 C), and wek mRNA levels were virtually 
absent in embryos and increased from L2 on (Fig. 7 C). wek 
expression was consistently lower than that of dsarm and equal 
to MyD88 from L2 onward (Fig. 7 C). The low levels of Wek 
in embryos suggest that in the embryonic CNS, Toll-6 can bind 
MyD88 to activate cell survival, but because there is no Wek, it 
cannot activate the dSarm proapoptotic pathway. In the pupa, 
VNCs and counted automatically with DeadEasy software. Box plot: Welch’s analysis of variance, P < 0.001, Dunnett’s post-hoc test. n = 5–16. Asterisks 
on graphs indicate post-hoc multiple comparisons corrections: *, P < 0.05; **, P < 0.01; ***, P < 0.001. For statistical details, see Table S2. > indicates 
GAL4/UAS. Bars: (B and C) 100 µm; (D and E) 50 µm.
 o
n
 January 29, 2018
jcb.rupress.org
D
ow
nloaded from
 
Cell number plasticity by DNTs and Tolls • Foldi et al. 1429
Figure 5. dSarm antagonizes MyD88 and promotes apoptosis downstream of Toll-6.  (A) Apoptotic cells visualized with anti-Dcp1 in pupal VNCs and 
quantified with DeadEasy. Box plots: left, Welch’s analysis of variance, P < 0.0001, Bonferroni’s post-hoc test; right, one-way analysis of variance, P < 0.0001, 
Tukey’s post-hoc test. n = 9–16. ns, not significant. (B) Eve+ neuron numbers in the abdominal VNCs of L3 larvae are regulated by dSarm. Box plot: one-way 
analysis of variance, P < 0.0001, Dunnett’s post-hoc test. n = 9–12. (C) Anti-GFP in dsarmMI08854-GFP is distributed throughout the embryonic CNS neuropile. 
(D) Loss and gain of dsarm function affects Eve+ neuron numbers in embryos (black arrows indicate neuronal loss, and red arrows indicate supernumerary 
neurons). For quantification, see Fig. S4. aCC, anterior corner cell; EL, Eve lateral. (E) dSarm can activate JNK signaling, seen with anti-pJNK in the larval ret-
ina. Box plot: one-way analysis of variance, P < 0.001, Dunnett’s post-hoc test. n = 4–18. (F) Coimmunoprecipitation from S2 cells showing that dSarm binds 
MyD88, but does not bind Toll-6 or -7. Arrows point to relevant bands. IB, immunoblot; IP, immunoprecipitation. Molecular masses are given in kilodaltons. 
(G) dSarm inhibits MyD88 and activates JNK, promoting apoptosis. Asterisks on graphs indicate post-hoc multiple comparisons corrections: **, P < 0.01; 
***, P < 0.001. See Table S2. > indicates GAL4/UAS. Bars: (A, C, and E) 50 µm; (B) 100 µm.
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in the presence of Wek, Toll-6 can activate either cell survival 
via MyD88 or cell death via dSarm. Thus, the temporal reg-
ulation of wek expression explains the different outcomes of 
Toll-6 function over time.
To visualize whether the spatial distribution of MyD88 
and dSarm may also change, we used a dsarmMIM IC-GFP in-
sertion and MyD88-GAL4NP6394 to drive the expression of 
membrane-tethered 10×UAS-myr-td-Tomato and anti-DsRed 
antibodies. Both were widely expressed throughout the em-
bryonic CNS neuropile (Figs. 4 and 5), widespread in larvae 
(Fig. 7 D), and more restricted in pupae (Fig. 7 E). In pupae, 
MyD88>myr-td-Tomato was distributed throughout the VNC, 
but prominently in thoracic interneurons potentially linked to 
the motor circuitry (Fig. 7 E). dSarmMIM IC-GFP was distributed 
Figure 6. Wek mediates the proapoptotic function of Toll-6 upstream of dSarm. (A) Apoptotic cells in the white pupal VNCs visualized with anti-Dcp1 and 
quantified with DeadEasy. Box plot: Welch’s analysis of variance, P < 0.001, Bonferroni’s post-hoc test. n = 8–16. (B and C) Overexpression of wek in 
all neurons with elav-GAL4 caused loss of Eve+ neurons in embryos (B; arrows indicate cells present in control and missing in elav>wek; quantification in 
Fig. S4) and pupae (C). Box plot: one-way analysis of variance, P < 0.001, Dunnett’s post-hoc test. Bars, 50 µm. n = 5–13. Asterisks on graphs indicate 
post-hoc multiple comparisons corrections: **, P < 0.01; ***, P < 0.001; ns, not significant. See Table S2. > indicates GAL4/UAS. (D) Coimmunopre-
cipitation from S2 cells showing that Wek binds Toll-6 and dSarm. IB, immunoblot; IP, immunoprecipitation. Molecular masses are given in kilodaltons. (E) 
Wek recruits dSarm and MyD88.
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throughout the VNC but prominently in ventral projections, 
apparently sensory circuits (Fig. 7 E). These distinct patterns 
suggest that after cell number regulation, neural circuits acquire 
a characteristic composition of Toll signaling adaptors.
Mammalian NTs can induce signaling from 
mammalian TLRs
To test whether the link between NTs and Toll receptors 
might also occur in mammals, we performed signaling assays 
with TLR2 and TLR4, which are cell membrane receptors 
present in the mammalian brain, and TLR5, an intracellular 
receptor (Gay et al., 2014). HEK293T cells were transfected 
with TLR2, 4, and 5 and an NF-κB luciferase reporter, and 
signaling was measured after stimulation with increasing 
concentrations of mature BDNF or NGF (Fig. S5). Whereas 
there was no effect upon stimulation of TLR2 or TLR5 with 
either NGF or BDNF, both ligands induced signaling in cells 
transfected with TLR4 (Fig. S5). Furthermore, treatment 
with NGF or BDNF altered the response of TLR2, 4, and 5 
to stimulation with their canonical innate immunity ligands 
(Fig. S5). This means that mammalian NTs can influence 
mammalian TLR signaling.
Figure 7. Adaptors matter and change in space 
and time. (A) Overexpression of wek or dsarm 
(EP3610) with MyD88-GAL4 decreased Eve+ neu-
ron numbers in pupal VNCs. Box plot (bottom): 
one-way analysis of variance, P < 0.001; Dunnett’s 
post-hoc test. n = 6–9. (B) MyD88-expressing cells 
visualized with MyD88-GAL4NP6394 and nuclear 
Histone-YFP are lost in pupae by altering levels 
of adaptors. Box plot (bottom): Welch’s analysis 
of variance, P < 0.001, Bonferroni’s post-hoc test. 
n = 5–9.  Dotted lines indicate medians of con-
trols. (C) qRT-PCR showing a temporal profile of 
mRNA levels for MyD88, dsarm, and wek from 
whole embryos, L2 and L3 larval CNSs, and pupal 
CNSs, normalized to MyD88 mRNA in embryos 
(three biological replicates; error bars represent 
means ± SD). wt, wild type; s.d., standard de-
viation. Asterisks on graphs indicate post-hoc 
multiple comparisons corrections: **, P < 0.01; 
***, P < 0.001. See Table S2. > indicates GAL4/
UAS. (D and E) Expression of MyD88 visualized 
with MyD88NP6394-GAL4>20×UAS-myr-td-tomato 
and anti-DsRed and of dsarm visualized with 
Ect4MI08854-GFP and anti-GFP in the VNC of L3 lar-
vae and pupae. Horizontal and transverse views are 
on the right for each. Bars, 50 µm.
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Discussion
DNTs and Tolls regulate cell number plasticity by promoting 
both cell survival and death in the Drosophila CNS through 
a three-tier mechanism.
In the first tier, each DNT has unique features conducive 
to distinctive functions (Fig. 8 A). Spz, DNT1, and DNT2 share 
with the mammalian NTs the unequivocal structure of the CK 
domain unique to this protein family. However, DNT1, DNT2, 
and Spz have distinct prodomain features and are processed 
differently, leading to distinct cellular outcomes (Fig.  8  B). 
Spz is only secreted full length and cleaved by serine prote-
ases (Hoffmann and Reichhart, 2002). DNT1 and 2 are cleaved 
intracellularly by conserved furins. In cell culture, DNT1 was 
predominantly secreted with a truncated prodomain (pro-
DNT1), whereas DNT2 was secreted mature. In vivo, both 
pro- and mature DNTs were produced from neurons. Interest-
ingly, DNT1 also has an isoform lacking the CK domain (Zhu 
et al., 2008), and Spz has multiple isoforms with truncated pro-
domains (DeLotto et al., 2001). Thus, in vivo, whether DNT1 
and 2 are secreted full length or cleaved and whether Spz is 
activated will depend on the proteases that each cell type may 
express. Pro-DNT1 activates apoptotic JNK signaling, whereas 
mature DNT1 and 2 activate the prosurvival NF-κB (Dorsal and 
Dif) and ERK signaling pathways. Mature Spz does not activate 
ERK. This first tier is evolutionarily conserved, as mammalian 
pro-NTs can promote cell death, whereas furin-cleaved mature 
NTs promote cell survival (Lu et al., 2005). NF-κB, JNK, and 
ERK are downstream targets shared with the mammalian NTs, 
downstream of p75NTR (NF-κB and JNK) and Trks (ERK), to 
regulate neuronal survival and death (Roux and Barker, 2002; 
Lu et al., 2005; Minichiello, 2009). Thus, whether a cell lives or 
dies will depend on the available proteases, the ligand type, and 
the ligand cleavage product it receives (Fig. 8 A).
In a second tier, we showed that the specific Toll family re-
ceptor activated by a DNT matters (Fig. 8 B). Toll-6 and -7 could 
maintain neuronal survival, whereas Toll-1 had a predominant 
proapoptotic effect. Because there are nine Tolls in Drosophila, 
some Tolls could have prosurvival functions, whereas others could 
have proapoptotic functions. Different Tolls also lead to different 
cellular outcomes in immunity and development (Tauszig et al., 
2000; Yagi et al., 2010; McIlroy et al., 2013; Meyer et al., 2014; 
Paré et al., 2014). Thus, the life or death of a neuron will de-
pend on the Toll or combination of Tolls it expresses (Fig. 8 B). 
We also showed that binding of Spz to Toll-1 is most likely 
unique, but DNT1 and 2 bind Toll-6 and -7 promiscuously, and, 
additionally, we showed that DNT1 and 2 with Toll-6 and -7 
activate NF-κB and ERK, whereas pro-DNT1 activates JNK. 
This suggests that ligand prodomains might alter the affinity for 
Toll receptors and/or facilitate the formation of heterodimers 
between different Tolls and/or with other coreceptors to induce 
cell death. A “DNT–Toll code” may regulate neuronal numbers.
In a third tier, available downstream adaptors determine 
the outcome between cell survival and death (Fig. 8 C). Toll-6 
and -7 activate cell survival by binding MyD88 and activating 
NF-κB and ERK (whether ERK activation depends on MyD88 
is not known), and Toll-6 can activate cell death via Wek, dSarm, 
and JNK signaling. We have shown that Toll-6 binds MyD88 and 
Wek, which binds dSarm, and that dSarm binds MyD88 and pro-
motes apoptosis by inhibiting MyD88 and activating JNK. Wek 
also binds MyD88 and Toll-1 (Chen et al., 2006). So, evidence 
suggests that Wek recruits MyD88 and dSarm downstream of 
Tolls (Fig. 8 C). Because Toll-6 binds both MyD88 and Wek 
and Wek binds both MyD88 and dSarm, Wek functions like a 
hinge downstream of Toll-6 to facilitate signaling via MyD88 or 
Figure 8. Three-tier regulation of cell number plasticity by DNTs and Tolls. 
(A) Tier 1: different ligand forms result from cleavage by furin proteases 
and isoforms and can lead to different cellular outcomes. Pro-, prodomain. 
(B) Tier 2: different Tolls can lead to different outcomes. (C) Tier 3: different 
adaptors downstream of Tolls drive alternative cellular outcomes. Adaptor 
expression changes in time and space. In embryos, Wek levels are low, 
and dSarm and MyD88 have independent functions. As Wek levels rise, 
it recruits dSarm and MyD88, and dSarm inhibits MyD88. Toll-6 promotes 
cell survival via MyD88 in the embryonic CNS, and with Wek it can also 
induce apoptosis in pupa. Surviving cells segregate into potentially over-
lapping but distinct neural circuits.
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dSarm, resulting in alternative outcomes. Remarkably, adaptor 
expression profiles change over time, switching the response to 
Toll-6 from cell survival to cell death. In the embryo, when both 
MyD88 and dSarm are abundant, there is virtually no Wek, and 
Toll-6 can only bind MyD88 to promote cell survival (Fig. 8 C). 
As Wek levels rise, Toll-6 signaling can also induce cell death. 
If the Wek-Sarm-JNK route prevails, Toll-6 induces apoptosis; 
if the Wek–MyD88–NF-κB route prevails, Toll-6 signaling in-
duces cell survival (Fig. 8 C).
Thus, the cellular outcome downstream of DNTs and 
Tolls is context and time dependent. Whether a cell survives 
or dies downstream of DNTs and Tolls will depend on which 
proteases are expressed nearby, which ligand it receives and in 
which form, which Toll or combination of Tolls it expresses, 
and which adaptors are available for signaling (Fig. 8).
How adaptor profiles come about or change is not un-
derstood. A neuronal type may be born with a specific adaptor 
gene expression profile, or Toll receptor activation may influ-
ence their expression. In fact, MyD88 reinforces its own sig-
naling pathway, as Toll-6 and -7 up-regulate Dorsal, Dif, and 
Cactus protein levels (McIlroy et al., 2013) and TLR activation 
increases Sarm levels (O’Neill and Bowie, 2007). We showed 
that apoptosis caused by MyD88 excess depends on JNK sig-
naling. Because JNK functions downstream of Wek and dSarm, 
this suggests that MyD88, presumably via NF-κB, can activate 
the expression of JNK, wek, or dsarm. By positively regulat-
ing wek expression, MyD88 and dSarm could establish positive 
feedback loops reinforcing their alternative pathways (Fig. 8 C, 
bottom). Because dSarm inhibits MyD88, mutual regulation 
between them could drive negative feedback. Positive and neg-
ative feedback loops underlie pattern formation and structural 
homeostasis and could regulate neuronal number in the CNS 
as well. Whether cell-autonomous or -nonautonomous mecha-
nisms result in the diversification of adaptor profiles, either in 
time or cell type, remains to be investigated.
Either way, over time the Toll adaptors segregate to dis-
tinct neural circuits, where they exert further functions in the 
CNS (Fig.  8  C). Toll-1, -6, and -8 regulate synaptogenesis 
and structural synaptic plasticity (Halfon et al., 1995; Ballard 
et al., 2014; McLaughlin et al., 2016). Sarm regulates neurite 
degeneration, and in the worm, it functions at the synapse to 
determine neuronal identity (Chuang and Bargmann, 2005; 
Osterloh et al., 2012). The reporters we used revealed a poten-
tial segregation of MyD88 to the motor circuit and dSarm to 
the sensory circuit, but this is unlikely to reflect the endoge-
nous complexity of Toll- signaling circuitry, as dsarmMIM IC− has 
a GFP insertion into one of eight potential isoforms, and dsarm 
also functions in the motor system (McLaughlin et al., 2016). 
Importantly, cell death in the normal CNS occurs mostly in late 
embryogenesis and in pupae, coinciding with neural circuit 
formation and remodeling, when neuronal number is actively 
regulated. Thus, the link by DNTs and Tolls from cell number 
to circuitry offers a complex matrix of possible ways to regulate 
structural plasticity in the CNS.
We have uncovered remarkable similarities between 
Drosophila Toll-6 and mammalian TLR signaling involving 
MyD88 and Sarm. All TLRs except TLR3 signal via MyD88 
and activate NF-κB (Gay and Gangloff, 2007; Gay et al., 2014). 
Neuronal apoptosis downstream of TLRs is independent of 
NF-κB and instead depends on TRIF and Sarm1 (Kaiser and 
Offermann, 2005; Ma et al., 2006; Kim et al., 2007; Mukherjee 
et al., 2013). Sarm1 is a negative regulator of TLR signaling, an 
inhibitor of MyD88 and TRIF (Carty et al., 2006). sarm1 is ex-
pressed in neurons, where it activates JNK and promotes apop-
tosis (Kim et al., 2007; Osterloh et al., 2012; Mukherjee et al., 
2013). However, the endogenous ligands for TLRs in the nor-
mal undamaged brains are not known. Our preliminary analysis 
has revealed the intriguing possibility that NTs either can bind 
TLRs or induce interactions between Trks, p75NTR, and TLRs. 
It is compelling to find out whether TLRs regulate structural 
plasticity in the mammalian brain in concert with NTs.
To conclude, DNTs with Tolls constitute a novel molec-
ular system for structural plasticity in the Drosophila CNS. 
This could be a general mechanism to be found also in the 
mammalian brain and in other contexts as well, such as epi-
thelial cell competition and regeneration, and altered in can-
cer and neurodegeneration.
Materials and methods
Genetics
Mutant and reporter stocks. Control stocks were yw and/or outcrosses 
of yw, as most transgenic flies were in a w− background. MyD88kra56 
is an ethyl methanesulfonate (EMS)–induced hypomorphic allele (a 
gift from B.  Moussian; Charatsi et al., 2003), and wekEX14 is an ex-
cision loss-of-function allele (a gift from J.L.  Imler, Centre National 
de la Recherche Scientifique, Strasbourg, France; Chen et al., 2006). 
dsarm4705 and dsarm4621 are loss-of-function alleles of dsarm (a gift 
from Marc Freeman, University of Massachusetts Medical School, 
Worcester, MA). The deficiency Df(2R)BSC279 lacks the MyD88 locus 
and Df(2L)BSC690 lacks the wek locus, respectively. Dorsal-GFP 
(w1118;PBac{dl-GFP.FLAG}VK00033/TM3, Sb1) and Dif-GFP 
(w1118;Pbac{Dif-GFP.FPTB}VK00033) are both GFP exon trap lines. 
Ect4MI00854 and sarm are synonyms for the same gene, and Ect4MIM IC-GFP 
(yw;MiMicECT4[MI08854]) is a MIM IC insertion bearing GFP into 
the Ect4 locus. Stocks were balanced using CyOlacZ and TM6BlacZ, 
to identify mutant embryos, or SM6aTM6B balancers carrying Tb−, to 
identify mutant larvae and pupae. Double and triple mutants and other 
stocks were generated by conventional genetics.
Overexpression in vivo. We used the following GAL4 driv-
ers: (a) w;; elav-GAL4 for all neurons; (b) w; GMR-GAL4 for the 
retina (a gift from Matthew Freeman, University of Oxford, Oxford, 
England, UK); (c) w; RG-GAL4 drives expression in the ring gland 
and in a small neuronal cluster in the optic lobes; and (d) w; MyD88-
GAL4: yw;P{GawB}MyD88NP6394/Cyo, P{UAS-lacZ.UW14}UW14 
(Bloomington Drosophila Stock Center). These were crossed to (a) the 
membrane-tethered reporter w;; 10×UAS-myr-td-Tomato (a gift from 
B.D. Pfeiffer, University of Texas Southwestern, Dallas, TX); (b) ac-
tivated forms of Tolls w;;UASToll-6CY and w;;UASToll-7CY (McIlroy et 
al., 2013) and UASToll-110b (a gift from J.M. Reichhart, University of 
Strasbourg, Strasbourg, France); (c) w; UAS-MyD88-FL (a gift from 
J. Kagan, Harvard Medical School, Boston, MA); (d) w; UAS-dsarm 
(a gift from Marc Freeman), which drives expression of the dsarm 
cDNA (Osterloh et al., 2012), and w1118;P{EP}EP3610/TM6B,Tb1, 
which drives expression of all Ect4 (dsarm) isoforms (Bloomington 
Drosophila Stock Center; Ect4 and sarm are synonyms for the same 
gene); (e) UAS-wek-HA; UAS-cactus-HA (FlyORF); or (f) w[11]; UAS-
JNK-RNAi [P(GD10555) (VDRC34138) and UAS-dsarmRNAi; UAS-
MyD88-RNAi (VDRC32396; Vienna Drosophila Research Center).
Structural modeling of DNTs and comparison to mammalian NTs
DNT1 and 2 were modeled on their closest structural homologue, Spz, 
using Modeller software (Webb and Sali, 2014), which builds ab initio 
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the loops that were not observed crystallographically in Spz. The same 
method was used to complete the 3D model of Spz. The structure of 
the BDNF protomer is known in the context of heterodimerization with 
either NT3 (Robinson et al., 1995) or NT4 (Robinson et al., 1999). We 
generated a 3D model of the BDNF homodimer based on these het-
erodimers by substituting the NT with BDNF and performing energy 
minimization in Modeller (Webb and Sali, 2014). Protein sequences 
were analyzed by Clustal Omega (Sievers et al., 2011) and Tcoffee 
(Notredame et al., 2000). Figures were generated in PyMol (DeLano 
Scientific) using the lowest energy models with least clashes and best 
geometry according to Verify3D (Bowie et al., 1991) and MolProbity 
(Chen et al., 2010), respectively.
Bioinformatics and sequence analysis
Analysis of prodomain. Analysis was performed using PSI PRED, a 
secondary structure prediction program.
Identification of conserved furin sites. Potential furin cleavage 
sites in DNT1 and 2 were identified by the PiTou prediction tool (Tian 
et al., 2012). To test the predicted cleavage sites, mutant DNT1 and 2 
constructs were generated by site-directed mutagenesis (see the Site-di-
rected mutagenesis section). S2 cells were transfected with full-length, 
truncated, or mutant forms of DNT1 or 2 cloned into pAct5c-3×HA ex-
pression vector (see the Cell culture, transfection, stimulation . . . sec-
tion). After transfection, cells were separated from culture media and 
lysed in NP-40 buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 1% 
Igepal CA-630). HA-tagged proteins in cell lysates and culture media 
were detected by anti-HA antibody using standard Western blots.
Primer design. Primers were designed using the public resource 
Primer3Plus. For site-directed mutagenesis, primers were designed using 
the QuickChange Primer Design online tool (Agilent Technologies). For 
qRT-PCR to detect which Toll receptors were expressed in S2 cells, Prim-
er-BLA ST was used to design specific primers.
Molecular biology
Generation of fusion constructs. Full-length or truncated cDNAs of 
DNT1 and 2 were cloned into an expression vector using a standard 
Gateway procedure, inserting them first into pDONR and subsequently 
into pAct5c-3×HA to generate the following constructs: pAct5c-DNT1-
FL-3×HA; pAct5c-DNT1 (Sp + CK + CTD) − 3×HA; pAct5c-DNT2-
FL-3×HA; and pAct5c-DNT2 (Sp + CK) − 3×HA. Cloning to generate 
HA-tagged dsarm was also performed using the Gateway system. 
dsarm cDNA was amplified from a pUAST-dsarm plasmid (a gift 
from Marc Freeman) and then was subcloned first into pDONR and 
subsequently into the destination vector, resulting in pAct5c-dsarm-
3×HA. UAS-DNT1-FL-GFP and UAS-DNT2-FL-GFP were tagged at 
the C terminus with GFP by cloning: DNT1-FL-GFP was cloned into 
pUASt using conventional ligation and transgenesis, and DNT2-FL-
GFP was cloned by Gateway cloning into pUAS-GW-GFP followed 
by conventional transgenesis, using white as the selection marker. For 
all primers, see Table S1.
Generation of MyD88cr2.8 mutant allele by CRI SPR/Cas9. A 
MyD88 CRI SPR mutant allele was created by designing a guide RNA 
targeting exon 1 of MyD88 using CRI SPR software (Massachusetts 
Institute of Technology) with the primers MyD88 BbSI sense, 5′-
GTC GCC GAG GGA GTT ATG GAC TCC-3′, and antisense, 5′-AAA 
CGG AGT CCA TAA CTC CCT CGG-3′, cloned in to the BbsI site of 
the pCFD3 U6.3 vector and verified by sequencing. Transgenic flies 
bearing U6.3 MyD88 guide RNA were generated by φC31 trans-
genesis (injections by BestGene Inc). Flies bearing the guide RNA 
(yscv;;U6.3MyD88gRNA attp2/TM3(sb)) were crossed to flies carrying 
Cas9 driven by the nanos promoter ym{nosCas9}ZH2A. Independent 
balanced stocks were established from F1 males (w;MyD88CRI SPR/CYO) 
and sequenced. MyD88cr2.8 bears a 7-bp deletion that causes a frame-
shift at amino acid 64 and a premature stop codon at amino acid 94. 
This corresponds to the start of the death domain (amino acids 90–172). 
This allele lacks the death and Toll–interleukin receptor domains and 
is therefore a null allele. The sequence of the lesion and the amino acid 
sequence are given in Table 1. 
RT-PCR. RT-PCR was performed to see which Toll receptors were 
expressed in S2 cells. Total RNA was isolated from S2 cells by TRIzol 
(Ambion) reagent following a standard protocol. Reverse transcription 
was performed by using the GoScript system (Promega). The standard 
PCR reaction was performed to amplify Toll receptor cDNA fragments 
using Taq DNA polymerase (Invitrogen). For a list of primers, see 
Table S1.
Site-directed mutagenesis. One or more point mutations were 
generated in pAct5c-DNT1-FL-3×HA and pAct5c-DNT2-FL-3×HA 
fusion constructs by site-directed mutagenesis according to Wang and 
Malcolm (1999). The following mutant expression clones were used 
for S2 cell transfection: pAct5c-DNT1-FL-R499G-3×HA, pAct5c-
DNT1-FL-R283/499G-3×HA, pAct5c-DNT2-FL-R284G, and pAct5c-
DNT2-FL-R214/221/284G-3×HA. For primers, see Table S1.
qRT-PCR. From 2  h–staged egg collections at 25°C, whole de-
chorionated embryos were harvested 20 h after egg laying (AEL), and 
the CNS was dissected from L2 larvae at 48 h AEL, L3 larvae at 96 h 
AEL, and pupae 0–12 h after puparium formation. Samples were then 
placed immediately into TRI reagent (AM9738; Ambion) and frozen 
at −80°C. Total RNA was extracted from 20 embryos or 20 dissected 
larval or pupal CNSs using TRl and following the manufacturer’s in-
structions. cDNA was synthesized from 200 ng of total RNA using the 
GOScript reverse transcription system (A5001; Promega) using ran-
dom primers and then diluted threefold for quantitative PCR reactions, 
Table 1. Lesion and amino acid sequences used to generate the MyD88CR2.8 allele
Allele Sequence (5′–3′)
Lesion
MyD88WT                            GTC AGT TAT CGG CGT TAT CGC ACC GCT GGC ATG GTG GTGGCC GAG GGA GTT ATG GAC TCC
MyD88CR2.8                            GTC AGT TAT CGG CGT TAT CGC ACC GCT GGC ATG GTG GTG GCC GAG GGA GTT ATG
MyD88WT                            GGG TCG GGA TCG GGC ACG GGA ACG GGC TTG GGG CAC TTC AAC GAG ACC CCA TTA TCC GCA
MyD88CR2.8                            GGT CGG GAT CGG GCA CGG GAA CGG GCT TGG GGC ACT TCA ACG AGA CCC CAT TAT CCG CA
Amino acid
MyD88WT                            MRP RFV CHQ QHS VAH SHY QPH SHF HHH THR HPN PPH HHH IYG ATD VSY RRY RTA GMVVAE
MyD88CR2.8                            MRP RFV CHQ QHS VAH SHY QPH SHF HHH THR HPN PPH HHH IYG ATD VSY RRY RTA GMVVAE
MyD88WT                            GVMDSGS GSG TGT GL------GHF NET PLS ALG IET RTQ LSR MLN RKK VLR SEE GYQ RDW
MyD88CR2.8                            GVMGRDR ARE RAW GTS TRP HYP HWA SRP APS CPACSTOP
Guide RNA sequences are given in bold.
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and 2  µl was used per reaction. “No reverse transcription” controls 
were run alongside cDNA reactions. Transcript levels were determined 
in triplicate for each sample using SensiFAST Hi-ROX SYBR green 
(BIO-92020; Bioline) run on a sequence detection system (ABI PRI 
SM 7000; Thermo Fisher Scientific). The reference gene was RpL32, 
as it remained constant over the course of development. Primers used 
are given in Table S1.
To obtain fold change values by using the 2−ΔΔCt method (Livak 
and Schmittgen, 2001) for the developmental profiles of MyD88, 
dsarm, and wek, the Ct value of Rpl32 was subtracted from the Ct value 
of each gene and developmental time point to obtain ΔCt. All values 
were then normalized to the calibrator, which. for this set of experi-
ments, was MyD88 mRNA at embryo (ΔΔCt). Three independent bio-
logical replicates were performed per experiment, and the mean ± SD 
is provided in Fig. 5 B.
Cell culture
Cell culture, transfection, stimulation, and subcellular fractionation. S2 
cells were maintained at 27°C in InsectXpress medium (Lonza) supple-
mented with 10% heat-inactivated FBS and 1% penicillin–streptomycin–
glutamine (Gibco). Transfection reagent (TransIT2020; Mirus) was used 
to express target proteins in S2 cells.
To stimulate S2 cells with mature DNT2-CK, S2 cells were 
transfected with pAct5c-Toll-6-3×HA or pAct5c-Toll-7-3×HA and 
were grown overnight in a 6-well plate (2 × 106 cells/well). Cells 
were serum starved for at least 6 h and then were treated with purified 
DNT2-CK (50 nM) for 5–60 min.
To separate nuclear and cytoplasmic fractions, cells were pelleted 
and washed in ice-cold PBS at 500 g for 5 min at 4°C. The cells were 
lysed in ice-cold harvest buffer (10 mM Hepes, pH 7.9, 50 mM NaCl, 
0.5 M sucrose, 0.1 mM EDTA, 0.5% TritonX-100, 1 mM DTT supple-
mented with a protease inhibitor cocktail [Thermo Fisher Scientific] 
and 5 mM NaF, and 2 mM Na3VO4) for 5 min on ice. Lysate was spun 
at 800 g for 10 min at 4°C. Supernatant was treated as cytoplasmic/
membrane and pellet was treated as nuclear fraction. The cytoplasmic/
membrane fraction was transferred in an empty tube and subsequently 
purified by centrifugation at 14,000 g for 10 min at 4°C. The nuclear 
pellet was resuspended in buffer A (10  mM Hepes, pH 7.9, 10  mM 
KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT supplemented with 
protease inhibitor cocktail and 5  mM NaF, and 2  mM Na3VO4) and 
spun at 800 g for 10 min at 4°C. Supernatant was discarded and the 
pellet was resuspended in buffer C (10 mM Hepes, pH 7.9, 500 mM 
NaCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% NP-40, 1 mM DTT sup-
plemented with a protease inhibitor cocktail and 5 mM NaF, and 2 mM 
Na3VO4) and incubated on ice for 30 min. Nuclear fraction was purified 
by centrifugation at 14,000 g for 10 min at 4°C.
To analyze total cell lysate, S2 cells were pelleted and washed in 
ice-cold PBS and then lysed in radioimmunoprecipitation assay buffer 
(10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton 
X-100, 0.1% SDS, 0.1% sodium deoxycholate supplemented with a 
protease inhibitor cocktail and 5 mM NaF, and 2 mM Na3VO4). Total 
cell lysate or subcellular fractions were analyzed by SDS-PAGE fol-
lowed by Western blotting using standard procedures.
Coimmunoprecipitations from cotransfected S2 cells. Coim-
munoprecipitations from S2 cells were performed as previously de-
scribed (McIlroy et al., 2013). S2 cells were transfected with the 
following combinations of plasmids: (a) pAct5c-Toll-6-3×HA and 
pAct5c- Pro-TEV6HisV5-DNT1-CK-CTD; pAct5c-Toll-7-3×HA 
and pAct5c-Pro-TEV6HisV5-DNT2-CK; (b) pAct5c-MyD88-V5 and 
pAct5c-Toll-6-3×Flag or pAct5c-Toll-6CY-3×Flag, pAct5c-Toll-7-
3×Flag, or pAct5c-Toll-7CY-3×Flag; (c) pAct5c-dsarm-3×HA and 
pAct5c-MyD88-V5; pAct5c-dsarm-3×HA and pAct5c-Toll-6CY-3×Flag 
or pAct5c-Toll-7CY-3×Flag; and (d) pAct5c-Wek-3×HA and pAct5c-
Toll6CY-3×Flag or pAct5c-dsarm-3×Flag. pAct5c-MyD88-V5 plasmid 
was a gift from S. Wasserman (University of San Diego, San Diego, 
CA); pAct5c-Wek-3×HA was a gift from J.L. Imler (Institut de Biolo-
gie Moléculaire et Cellulaire, Strasbourg, France). Cells were collected 
48 h after transfection and lysed in NP-40 buffer or in Flag affinity chro-
matography buffer (50 mM Hepes, pH 7.5, 80 mM KCl, 5 mM MgCl2, 
2 mM EGTA, and 0.2% Triton X-100) supplemented with protease in-
hibitor cocktail. Immunoprecipitations from lysates were performed using 
mouse anti-V5 antibody in combination with protein-A/G magnetic beads 
(Thermo Fisher Scientific) or anti-Flag antibody-conjugated agarose or 
magnetic beads (Sigma-Aldrich). Proteins were analyzed by SDS-PAGE 
and Western blotting as described in the Western blots section.
Luciferase reporter assay in mammalian cells. HEK293 cells 
were seeded at 105 cells/well in a 96-well plate 36 h before transfection 
with jetPEI (Polyplus). NF-κB–dependent gene expression was deter-
mined using a luciferase reporter construct concomitantly with indi-
cated TLR vectors. The Renilla luciferase-thymidine kinase–encoding 
plasmid (pRL-TK) was used to normalize for transfection efficiency, 
and pcDNA3.1 empty vector was used to maintain constant DNA. 
Cells were stimulated in a dose-dependent manner using neurotrophic 
agents hNGF-β (H9666; Sigma-Aldrich), hBDNF (R&D Systems), 
or mNGF-7S (N0513; Sigma-Aldrich). Transfected cells were lysed 
using Passive lysis buffer and assayed for luciferase and Renilla activ-
ity using luciferase assay reagent (Promega). Luminescence readings 
were corrected for Renilla activity and expressed as fold increases over 
unstimulated control values. Data are presented as means ± SEM of one 
of three independent experiments. Statistical analysis was performed 
using a two-way analysis of variance where we compared TLR sig-
naling upon stimulation with varying concentrations of NTs or upon 
stimulation with both canonical innate immunity ligands and NTs.
Immunostainings
In vivo immunostainings in the larval and pupal CNS. Dissections, fix-
ations, and immunostainings were performed following standard pro-
cedures, except that for stainings to detect apoptosis in the pupal CNS, 
only pupae within the first 10 min of puparium formation were used 
in order to minimize biological variability in apoptosis levels over time. 
Primary antibodies used were rabbit anti-GFP (1:500 in larvae and pupae, 
1:1,000 in embryos; A11122; Invitrogen), rabbit anti-DsRed (1:100; 
632496; Takara Bio Inc.), rabbit anti-βgal (1:5,000; Cappel), mouse 
anti-Eve (1:5–1:10; 2B8; Developmental Studies Hybridoma Bank), 
mouse anti-Eve (1:20; 3C10; Developmental Studies Hybridoma Bank), 
mouse anti-pERK (1:500 in retina and 1:100 in optic lobe; 9106; Cell 
Signaling Technology), mouse anti-Repo (1:250; 8D12; Developmental 
Studies Hybridoma Bank), rabbit anti-pJNK (1:200; V7931; Promega), 
rabbit anti-Myd88 (1:250; a gift from S. Wasserman), and rabbit anti-Dcp1 
(cleaved Drosophila Dcp1 [Asp216]; 1:500; 9578S; Cell Signaling Tech-
nology). Secondary antibodies were directly conjugated Alexa Fluor 488, 
546, and 647 (1:250, Molecular Probes) or biotinylated mouse or rabbit 
(1:300) followed by avidin amplification using the Vectastain ABC Elite kit 
(Vector Laboratories) or the Tyramide Signal Amplification kit (T20922; 
Thermo Fisher Scientific), using the manufacturer’s instructions. For sam-
ple sizes, see Table S2.
Western blots. Western blotting was performed according to 
standard procedures. Primary antibodies used were mouse anti-V5 
(1:5,000; R960-25; Invitrogen), rabbit anti-Flag (1:2,000; F7425; 
Sigma-Aldrich), mouse anti–histone-H1 (1:10,000; 05-629; EMD 
Millipore), mouse antitubulin (1:10,000; T9026; Sigma-Aldrich), 
chicken anti-HA (1:2,000 and 1:5,000; ET-HA100; Aves Lab), mouse 
anti-HA (12CA5; 1:2,000; 11 583 816 001; Roche), mouse anti-Dorsal 
(7A4; 1:500; Developmental Studies Hybridoma Bank), mouse anti- 
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Cactus (3H1; 1:500; Developmental Studies Hybridoma Bank), and rab-
bit anti-Dif (1:500; a gift from D. Ferrandon, University of Strasbourg, 
Strasbourg, France). Secondary antibodies used were anti-mouse HRP 
(1:5,000; PI-2000; Vector Laboratories), anti-rabbit HRP (1:5,000; PI-
1000; Vector Laboratories), and anti-chicken HRP (1:10,000; 703-035-
155; Jackson ImmunoResearch Laboratories, Inc.).
Microscopy and imaging
Imaging. For microscopy, samples were mounted either in 70% glyc-
erol and 30% PBTriton (larval and pupal fluorescent CNS and non-
fluorescent embryos) or in Vectashield (H-1000; Vector Laboratories; 
fluorescent embryonic CNS). Wide-field microscopy was performed 
with a microscope (Axioplan 2; ZEI SS) and a 63× objective; images 
were taken under Nomarski optics with an AxioCam color camera 
and Zen software (ZEI SS). Fluorescent microscopy was performed 
using secondary antibodies directly conjugated to Alexa Fluor 488, 
546, and 647. Laser-scanning confocal microscopy was performed at 
room temperature using a spectral confocal microscope (SP2 AOBS; 
Leica Microsystems) and a 40× or 63× lens at 512 × 512– or 1,024 × 
1,024–pixel resolution and with 0.5- or 1-µm steps or a laser-scanning 
microscope (LSM 710; ZEI SS) with a 25× oil lens at 512 × 512–pixel 
resolution and with 1-µm steps. Confocal image acquisition was per-
formed with Leica Microsystems or ZEI SS software as per the system. 
Each confocal stack comprised 100–300 images, which were processed 
as follows: (a) for image data, ImageJ (National Institutes of Health) 
was used to view the entire stack of images, carry out horizontal and 
transverse projections, and rotate images; occasionally, a median or 
“dust and scratches” filter was applied to a projection image over the 
whole image. Photoshop (Adobe) was used to adjust levels, rotate and 
crop images, and adjust image size to 300 dpi. Illustrator (Adobe) was 
used to compile figure plates. (b) For quantitative data (e.g., number 
of Dcp1+, Eve+, or YFP+ cells), we used the ImageJ plugins DeadEasy 
Larval Glia (which counts nuclear stains) and DeadEasy Caspase for 
Larvae (for apoptotic cells) as previously described and validated 
(Forero et al., 2009, 2012; Kato et al., 2011). DeadEasy analyzes the 
entire stacks of images in 3D, identifies cells based on pixel intensity 
and 3D volume, and counts cells automatically in an entire CNS in 
3D in less than a minute.
Quantitative data analysis. Penetrance is the frequency with 
which a phenotype is manifested within a population, and expressivity 
is the severity of the phenotype. Eve+ cells in embryos analyzed under 
wide-field Nomarski optics were counted manually under an Axioplan 
2 microscope and a 63× objective. Fluorescent pJNK+ cells in the retina 
were counted manually within the stacks of confocal sections using 
ImageJ and the Cell Counter macro.
Dcp1+ apoptotic cells from the entire VNC of the CNS were 
counted automatically using DeadEasy Caspase for Larvae(Forero 
et al., 2009), specific for apoptotic cells and optimized for the larval/
pupal CNS (Kato et al., 2011). The entire VNC was counted, using the 
edges of the optic lobes as anterior boundaries. Eve+ cells in the larval 
CNS were counted automatically with DeadEasy Larval Glia software, 
which counts nuclear stains (see previous section; Forero et al., 2012). 
For Eve+ cell counting, the thoracic (T1–T3) and posterior tip cells 
were excluded because cells there are too packed together, and only the 
cells from abdominal segments A1–A6 were counted.
Quantification of pixel intensity was performed with ImageJ, set-
ting fixed regions of interest over the area posterior to the morphogenetic 
furrow or over the morphogenetic furrow, and the mean intensity in this 
area was normalized over the mean intensity of a fixed region of interest 
over the eye disk anterior to the morphogenetic furrow.
Statistical analysis. Statistical analyses were performed using 
SPSS (IBM) and Prism (GraphPad Software). Continuous data (e.g., 
the number of Dcp1+, pJNK+, and Eve+ cells) were analyzed first for 
normality, using curve shape or kurtosis and skewness, and then test-
ing the homogeneity of variance with a Levene’s test. If the Levene’s 
test was not significant, a one-way analysis of variance was used, and 
Welch analysis of variance was used if samples did not pass the Levene’s 
test. Multiple genotypes were compared with a single control with Dun-
nett’s post-hoc test or were compared with each other using Bonferroni’s 
multiple comparison corrections tests. For TLR signaling, data were an-
alyzed using a two-way analysis of variance, and Dunnett’s post-hoc 
tests were used for multiple comparisons to NT = 0 controls. For ge-
netic experiments, reproducibility was confirmed by the overall large 
population sizes and consistent results in multiple repetitions of the ex-
periments; for cell culture data, qRT-PCR, and coimmunoprecipitations, 
the experiments were performed at least three times. All p-values, tests, 
and sample sizes are provided in figure legends, and further details are 
in Table S2.
Online supplemental material
Fig. S1 shows how structural analysis of the prodomains of Spz, DNT1, 
and DNT2 revealed unique features in each ligand. Fig. S2 shows S2 
cells expressing Toll-1, -2, -5, -7, and -8. Fig. S3 shows how DNT1 and 
2 bind Toll-6 and -7 promiscuously. Fig. S4 shows the penetrance of 
Eve+ neuron number phenotypes in the embryonic CNS. Fig. S5 shows 
how mammalian NTs elicit signaling from TLR4 and alter the response 
of several TLRs to their canonical immunity ligands. Table S1 is a list 
of primers used, and Table S2 is a list of all genotypes, sample sizes, 
and statistical analysis details.
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